RBSH — Rebus Holdings Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.31m
Annual income statement for Rebus Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.514 | 0.484 | 2.15 | -0.094 | 0.688 |
Operating Profit | -0.514 | -0.484 | -2.15 | 0.094 | -0.688 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.012 | -0.934 | -6.29 | 2.7 | -1.02 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.012 | -0.934 | -6.29 | 2.7 | -1.02 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.012 | -0.934 | -6.29 | 2.7 | -1.02 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.208 | -0.988 | -6.36 | 2.7 | -1.02 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1,012 | -356 | -1.91 | 0.075 | -0.031 |